Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in two upcoming investor conferences.

The Company will present at the Morgan Stanley Healthcare Conference in New York on Friday, September 6, 2024 at 7:00 a.m. (ET), and at the Bank of America Global Healthcare Conference in London on Wednesday, September 18, 2024 at 2:10 p.m. (BST). A live webcast of each event will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section. Replays of the webcasts will be available for approximately 90 days after each event.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.

For more information, please visit www.stevanatogroup.com.

Media Stevanato Group media@stevanatogroup.com

Investor Relations Lisa Miles lisa.miles@stevanatogroup.com

Stevanato (NYSE:STVN)
過去 株価チャート
から 11 2024 まで 12 2024 Stevanatoのチャートをもっと見るにはこちらをクリック
Stevanato (NYSE:STVN)
過去 株価チャート
から 12 2023 まで 12 2024 Stevanatoのチャートをもっと見るにはこちらをクリック